The Issue with Keloid Scars Keloid scars affect 18 million people, and many of them go through life believing that treatment for their embarrassing and sometimes painful scarring is impossible or even non-existent. Thick, unsightly keloid scars can significantly affect an individual’s confidence, but with the SRT-100™, you can help them gain it back. Restore […]
Blog
Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide
BOCA RATON, Fla, Jan. 22, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it has shipped and installed a Sculptura™ radiation oncology system to Stanford Health Care in Palo Alto, Calif. The system was […]
What Your Patients Should Know About Childhood Skin Cancer
September is Childhood Cancer Awareness month, a campaign to spotlight the types of cancer that largely affect children, draw attention to survivorship issues and raise funds for research and family support. In the US, more than 15,000 children aged younger than 21 years are diagnosed with cancer every year. Of those, the National Cancer Institute […]
Non-Melanoma Skin Cancer & What You Probably Did Not Know
Non-melanoma skin cancer has reportedly increased “33% since 2012” (Practical Dermatology, September 2019). For these skin cancer-related cases, there was reportedly “3.5 million total procedures in 2018… 3.35 million being for non-melanoma skin cancer” (Practical Dermatology, September 2019). With these increasing numbers, persons are turning to their local physicians for skin cancer checks. What physicians […]
Sensus Healthcare Announces Management Promotions
New corporate structure positions company for 2020 financial goals BOCA RATON, Fla., Jan. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces management promotions to better support the company’s financial goals for profitability in 2020 and beyond. […]
85.6% Cure Rate for Keloids Treated by SRT Post Surgery
Those who suffer from keloid scarring are often left wondering what they can do to finally get rid of their keloids for good. Superficial Radio Therapy is quickly becoming a popular solution to treat keloids after surgical removal. A retrospective study from early 2019 shows that there is an 85.6% cure rate for keloids using […]
Battling Skin Cancer? Look No Further than the Non-Surgical SRT-100™ for Your Squamous Cell Carcinoma Treatment
Squamous cell carcinoma is the second most common type of skin cancer. There are more than 700,000 new cases diagnosed each year in the United States. Fortunately, there is a new Squamous Cell Carcinoma Treatment available through Sensus Healthcare – The SRT-100™. What is Squamous Cell Carcinoma? Squamous cell carcinoma develops in the thin, flat […]
SRT-100™: Cure Your Patients with This Revolutionary Non-Surgical Squamous Cell Carcinoma Treatment
Each year, there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and colon. Nearly four million people in the United States will be diagnosed with basal cell or squamous cell carcinoma this year, with an estimated 700,000 of those cases diagnosed as squamous cell carcinoma. Squamous […]
Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference
BOCA RATON, Fla., Nov. 21, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December […]
Sensus Healthcare Reports Third Quarter 2019 Financial Results
Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 06, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2019. Highlights from the […]
Sensus Healthcare to Host Third Quarter 2019 Financial Results and Business Update Conference Call on November 6, 2019
BOCA RATON, Fla., Nov. 01, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter […]
2019 MEDICA Fair
Join Sensus Healthcare at the 2019 MEDICA Fair from November 18-21 in Dusseldorf, Germany. For more information click here.
2019 New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium
Join Sensus Healthcare at the 9th Annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium from November 16-17 in Hasbrouck Heights, NJ. For more information click here.
2019 ASDS Annual Meeting
Join Sensus Healthcare at the 2019 ASDS Annual Meeting from October 24-27 in Chicago, IL. For more information click here.
Penn-Ohio AAPM: Novel Technologies in Radiation Physics
Join Sensus Healthcare at Penn-Ohio AAPM: Novel Technologies in Radiation Physics from October 25-26 in Mayfield Village, OH. For more information click here.
SRT is a Great Alternative for Treating Non Melanoma Skin Cancer vs using Mohs Surgery
At Sensus Healthcare, our focus is on excellent patient outcomes. Studies have proven that Superficial Radio Therapy (SRT), is a highly effective treatment for Non-Melanoma Skin Cancer (NMSC) vs using Mohs surgery. NMSC includes Basal Cell Carcinoma and Squamous Cell Carcinoma. These cancers are rarely life-threatening but can cause complications if they are left untreated. […]
Sensus Healthcare Reports Second Quarter 2019 Financial Results
· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 08, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments […]
Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
BOCA RATON, Fla., July 30, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter […]
SRT & Keloid Treatment: Tony Perkins Interview
We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how utilizing superficial radiation therapy (SRT) as his post-operative keloid treatment help changed his life. Throughout Tony’s lifetime, he received several surgical treatments – none of which seemed to stop the continuous growth of his facial […]
TLC’s Dr. Pimple Popper Treats Keloids with SRT
Dr. Sandra Lee a.k.a Dr. Pimple Popper treats keloids with Sensus Healthcare’s SRT-100™. Thank you, Dr. Lee, for showing what amazing capabilities superficial radiation therapy can have when used on keloids directly after surgical removal! Here are some before and afters of the patient treated by Dr. Sandra Lee. If you did not catch Sensus’ […]